Timing underpins the benefits associated with injectable collagen biomaterial therapy for the treatment of myocardial infarction
Nick J. R. Blackburn(University of Ottawa), Erik J. Suuronen(University of Ottawa), Drew Kuraitis(University of Ottawa), Katey J. Rayner(University of Ottawa), Tanja Sofrenovic(University of Ottawa), Marc Ruel(University of Ottawa), Chao Deng(Jiangnan University), Ali Ahmadi(Shahrekord University of Medical Sciences), Brian McNeill(University of Ottawa), Zhiyuan Zhong(Soochow University)
Cited by 101
Related Papers
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
|The Lancet|2023|4.5k
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
|Nature|2010|4k
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
|JAMA Oncology|2021|2.1k
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
|Nature Immunology|2009|1.5k